Recombinant multi-species BCOR protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BCOR protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene was identified as an interacting corepressor of BCL6, a POZ/zinc finger transcription repressor that is required for germinal center formation and may influence apoptosis. This protein selectively interacts with the POZ domain of BCL6, but not with eight other POZ proteins. Specific class I and II histone deacetylases (HDACs) have been shown to interact with this protein, which suggests a possible link between the two classes of HDACs. Several transcript variants encoding different isoforms have been found for this gene. A pseudogene of this gene is found on chromosome Y.[provided by RefSeq, Jun 2010]
The Alternative Names of target: 2900008C10Rik,5830466J11Rik,8430401K06Rik,ANOP2,BCL-6 corepressor,BCOR,BCoR,Bcor,BcorR,D930024N20Rik,MAA2,MCOPS2,RGD1562735,mKIAA1575
Go
to BCOR products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP9859-Ag-1/ GM-Tg-hg-IP9859-Ag-2 | Human BCOR protein | Human |
| GM-Tg-rg-IP9859-Ag-1/ GM-Tg-rg-IP9859-Ag-2 | Rat BCOR protein | Rat |
| GM-Tg-mg-IP9859-Ag-1/ GM-Tg-mg-IP9859-Ag-2 | Mouse BCOR protein | Mouse |
| GM-Tg-cynog-IP9859-Ag-1/ GM-Tg-cynog-IP9859-Ag-2 | Cynomolgus/Rhesus macaque BCOR protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP9859-Ag-1/ GM-Tg-felg-IP9859-Ag-2 | Feline BCOR protein | Feline |
| GM-Tg-cang-IP9859-Ag-1/ GM-Tg-cang-IP9859-Ag-2 | Canine BCOR protein | Canine |
| GM-Tg-bovg-IP9859-Ag-1/ GM-Tg-bovg-IP9859-Ag-2 | Bovine BCOR protein | Bovine |
| GM-Tg-equg-IP9859-Ag-1/ GM-Tg-equg-IP9859-Ag-2 | Equine BCOR protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP9859-Ag-1/ GM-Tg-hg-IP9859-Ag-2;
GM-Tg-rg-IP9859-Ag-1/ GM-Tg-rg-IP9859-Ag-2;
GM-Tg-mg-IP9859-Ag-1/ GM-Tg-mg-IP9859-Ag-2; GM-Tg-cynog-IP9859-Ag-1/ GM-Tg-cynog-IP9859-Ag-2; GM-Tg-felg-IP9859-Ag-1/ GM-Tg-felg-IP9859-Ag-2; GM-Tg-cang-IP9859-Ag-1/ GM-Tg-cang-IP9859-Ag-2; GM-Tg-bovg-IP9859-Ag-1/ GM-Tg-bovg-IP9859-Ag-2; GM-Tg-equg-IP9859-Ag-1/ GM-Tg-equg-IP9859-Ag-2 |
| Products Name | BCOR protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | BCOR |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BCOR protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.